Clinical trial

A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases

NCT07782450

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention PF-08154225 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-11-19

PhasePHASE1 / PHASE2

Conditions

Systemic Lupus Erythematosusverified · MONDO: systemic lupus erythematosus

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Idiopathic Inflammatory Myositisverified · MONDO: acquired idiopathic inflammatory myopathy

Systemic Sclerosisverified · MONDO: systemic sclerosis

Interventions

PF-08154225DRUG

Sponsors & collaborators

Pfizerlead sponsor

Syneoscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07782450 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.